{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T02:02:05Z","timestamp":1780970525266,"version":"3.54.1"},"reference-count":49,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T00:00:00Z","timestamp":1650672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Osteoporosis is a common metabolic bone disease in patients with diabetes, which can develop simultaneously with type 2 diabetes (T2D) in postmenopausal women. Bisphosphonate (BP) is administered to patients with both conditions and may cause medication-related osteonecrosis of the jaw (MRONJ). It affects the differentiation and function of osteoclasts as well as the thickness of the cortical bone through bone mineralization. Therefore, this study aimed to investigate the effects of T2D on osteoclast differentiation and activity as well as cortical bone formation in postmenopausal patients with MRONJ. Tissue samples were collected from 10 patients diagnosed with T2D and stage III MRONJ in the experimental group and from 10 patients without T2D in the control group. A histological examination was conducted, and the expression of dendritic cell-specific transmembrane protein (DC-STAMP) and tartrate-resistant acid phosphatase (TRAP) was assessed. Cortical bone formation was analyzed using CBCT images. The number of TRAP-positive osteoclasts and DC-STAMP-positive mononuclear cells was significantly less in the experimental group (p &lt; 0.05). Furthermore, the thickness and ratio of cortical bone were significantly greater in the experimental group (p &lt; 0.05). In conclusion, T2D decreased the differentiation and function of osteoclasts and increased cortical bone formation in postmenopausal patients with MRONJ.<\/jats:p>","DOI":"10.3390\/jcm11092377","type":"journal-article","created":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T21:39:45Z","timestamp":1650749985000},"page":"2377","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effects of Type 2 Diabetes Mellitus on Osteoclast Differentiation, Activity, and Cortical Bone Formation in POSTmenopausal MRONJ Patients"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8573-9071","authenticated-orcid":false,"given":"Sung-Min","family":"Park","sequence":"first","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook University, 119 Dandae-ro, Cheonan 31116, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9959-4632","authenticated-orcid":false,"given":"Jae-Hoon","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook University, 119 Dandae-ro, Cheonan 31116, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00223-003-0023-7","article-title":"Diabetes Mellitus: Does it Affect Bone?","volume":"73","author":"Schwartz","year":"2003","journal-title":"Calcif. Tissue Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1023\/B:REMD.0000032415.83124.20","article-title":"Osteoporosis and Diabetes Mellitus","volume":"5","author":"Inzerillo","year":"2004","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00198-005-0013-x","article-title":"Diabetes mellitus and the risk of non-vertebral fractures: The Troms\u00f8 study","volume":"17","author":"Ahmed","year":"2005","journal-title":"Osteoporos. Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.bone.2007.02.021","article-title":"Biphasic fracture risk in diabetes: A population-based study","volume":"40","author":"Leslie","year":"2007","journal-title":"Bone"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.2337\/diacare.24.7.1192","article-title":"Iowa Women\u2019s Health Study. Type 1 and Type 2 Diabetes and Incident Hip Fractures in Postmenopausal Women","volume":"24","author":"Nicodemus","year":"2001","journal-title":"Diabetes Care"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Lin, H.-H., Hsu, H.-Y., Tsai, M.-C., Hsu, L.-Y., Chien, K.-L., and Yeh, T.-L. (2021). Association between type 2 diabetes and osteoporosis risk: A representative cohort study in Taiwan. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0254451"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/aje\/kwm106","article-title":"Systematic Review of Type 1 and Type 2 Diabetes Mellitus and Risk of Fracture","volume":"166","author":"Janghorbani","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","article-title":"Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes\u2014A meta-analysis","volume":"18","author":"Vestergaard","year":"2006","journal-title":"Osteoporos. Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1210\/jc.2006-0614","article-title":"Risk of Fracture in Women with Type 2 Diabetes: The Women\u2019s Health Initiative Observational Study","volume":"91","author":"Bonds","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1359\/jbmr.080323","article-title":"Fracture Risk in Type 2 Diabetes: Update of a Population-Based Study","volume":"23","author":"Melton","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.metabol.2014.09.002","article-title":"Type 2 diabetes mellitus and fracture risk","volume":"63","author":"Dede","year":"2014","journal-title":"Metabolism"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jbmr.2106","article-title":"In Vivo Assessment of Bone Quality in Postmenopausal Women with Type 2 Diabetes","volume":"29","author":"Farr","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1210\/jc.2017-00042","article-title":"Type 2 Diabetes and Osteoporosis: A Guide to Optimal Management","volume":"102","author":"Paschou","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bone.2016.06.017","article-title":"Teriparatide in patients with osteoporosis and type 2 diabetes","volume":"91","author":"Schwartz","year":"2016","journal-title":"Bone"},{"key":"ref_15","first-page":"14","article-title":"Osteoporosis: An understated complication of diabetes","volume":"34","author":"Vagula","year":"2009","journal-title":"US Pharm"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1056\/NEJMoa0802633","article-title":"Giant Osteoclast Formation and Long-Term Oral Bisphosphonate Therapy","volume":"360","author":"Weinstein","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Mac-Way, F., Trombetti, A., No\u00ebl, C., and Lafage-Proust, M.-H. (2014). Giant osteoclasts in patients under bisphosphonates. BMC Clin. Pathol., 14.","DOI":"10.1186\/1472-6890-14-31"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"srep36129","DOI":"10.1038\/srep36129","article-title":"Skeletal Site-specific Effects of Zoledronate on in vivo Bone Remodeling and in vitro BMSCs Osteogenic Activity","volume":"7","author":"Gong","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-017-1230-8","article-title":"Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: A comparison with osteoradionecrosis and osteomyelitis","volume":"15","author":"Gross","year":"2017","journal-title":"J. Transl. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1002\/jcp.25389","article-title":"DC-STAMP: A Key Regulator in Osteoclast Differentiation","volume":"231","author":"Chiu","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"ref_21","first-page":"204","article-title":"Osteoclastogenesis\u2014Current knowledge and future perspectives","volume":"8","author":"Yavropoulou","year":"2008","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00774-013-0434-0","article-title":"Lentivirus-mediated RNA interference of DC-STAMP expression inhibits the fusion and resorptive activity of human osteoclasts","volume":"31","author":"Zeng","year":"2013","journal-title":"J. Bone Miner. Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1084\/jem.20050645","article-title":"DC-STAMP is essential for cell\u2013cell fusion in osteoclasts and foreign body giant cells","volume":"202","author":"Yagi","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/jcb.20835","article-title":"Secretion of tartrate-resistant acid phosphatase by osteoclasts correlates with resorptive behavior","volume":"98","author":"Kirstein","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1242\/dev.122.10.3151","article-title":"Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis","volume":"122","author":"Hayman","year":"1996","journal-title":"Development"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1002\/jbmr.261","article-title":"Bone morphology in response to alendronate as seen by high-resolution computed tomography: Through a glass darkly","volume":"25","author":"Seeman","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.oooo.2011.11.011","article-title":"Mandibular cortical bone evaluation on cone beam computed tomography images of patients with bisphosphonate-related osteonecrosis of the jaw","volume":"113","author":"Torres","year":"2012","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40902-018-0153-5","article-title":"Evaluation of mandibular cortical bone ratio on computed tomography images in patients taking bisphosphonates","volume":"40","author":"Koo","year":"2018","journal-title":"Maxillofac. Plast. Reconstr. Surg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw\u20142014 Update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_30","first-page":"369","article-title":"Modulation of osteoblast activity by serum from diabetic and non-diabetic patients on hemodialysis: A three-dimensional culture study","volume":"17","author":"Serrano","year":"2004","journal-title":"J. Nephrol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S8756-3282(97)00220-2","article-title":"Growth-Inhibitory Effect of a High Glucose Concentration on Osteoblast-like Cells","volume":"22","author":"Terada","year":"1998","journal-title":"Bone"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/1097-4644(20001101)79:2<301::AID-JCB130>3.0.CO;2-0","article-title":"Extracellular glucose influences osteoblast differentiation and c-jun expression","volume":"79","author":"Zayzafoon","year":"2000","journal-title":"J. Cell. Biochem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/jcb.20842","article-title":"Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways","volume":"99","author":"Botolin","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.bone.2008.02.006","article-title":"High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis","volume":"42","author":"Wittrant","year":"2008","journal-title":"Bone"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.phymed.2010.04.003","article-title":"Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs\/NF-\u03baB regulated HIF-1\u03b1 and PGE2 synthesis","volume":"18","author":"Hsieh","year":"2011","journal-title":"Phytomedicine"},{"key":"ref_36","first-page":"105","article-title":"Low serum osteoprotegerin levels in normoalbuminuric type 1 diabetes mellitus","volume":"47","author":"Singh","year":"2009","journal-title":"Geol. Rundsch."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3892\/mmr.2014.2807","article-title":"High glucose inhibits receptor activator of nuclear factor-\u03baB ligand-induced osteoclast differentiation via downregulation of v-ATPase V0 subunit d2 and dendritic cell-specific transmembrane protein","volume":"11","author":"Xu","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.bbrc.2018.10.059","article-title":"Zoledronate and high glucose levels influence osteoclast differentiation and bone absorption via the AMPK pathway","volume":"505","author":"Dong","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"41147","DOI":"10.1074\/jbc.M205063200","article-title":"Large Scale Gene Expression Analysis of Osteoclastogenesisin Vitro and Elucidation of NFAT2 as a Key Regulator","volume":"277","author":"Ishida","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00774-006-0697-9","article-title":"Role of DC-STAMP in cellular fusion of osteoclasts and macrophage giant cells","volume":"24","author":"Yagi","year":"2006","journal-title":"J. Bone Miner. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/jbmr.531","article-title":"Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP)","volume":"27","author":"Chiu","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0714.2006.00391.x","article-title":"Osteonecrosis of the jaws in patients treated with bisphosphonates-histomorphologic analysis in comparison with infected osteoradionecrosis","volume":"35","author":"Hansen","year":"2006","journal-title":"J. Oral Pathol. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","article-title":"Cellular and molecular mechanisms of action of bisphosphonates","volume":"88","author":"Rogers","year":"2000","journal-title":"Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e28119","DOI":"10.4161\/sgtp.28119","article-title":"Modulation of osteoclast differentiation and bone resorption by Rho GTPases","volume":"5","author":"Touaitahuata","year":"2014","journal-title":"Small GTPases"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-pathol-011110-130203","article-title":"Disorders of Bone Remodeling","volume":"6","author":"Feng","year":"2011","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1359\/jbmr.070109","article-title":"Are Nonresorbing Osteoclasts Sources of Bone Anabolic Activity?","volume":"22","author":"Karsdal","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.bone.2003.08.004","article-title":"Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs","volume":"33","author":"Burr","year":"2003","journal-title":"Bone"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10654-012-9674-x","article-title":"Association between bone mineral density and type 2 diabetes mellitus: A meta-analysis of observational studies","volume":"27","author":"Ma","year":"2012","journal-title":"Eur. J. Epidemiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jbmr.2419","article-title":"Cortical Bone: A Challenging Geography","volume":"30","author":"Zebaze","year":"2014","journal-title":"J. Bone Miner. Res."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/9\/2377\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:59:33Z","timestamp":1760137173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/9\/2377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,23]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["jcm11092377"],"URL":"https:\/\/doi.org\/10.3390\/jcm11092377","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints202203.0408.v1","asserted-by":"object"}]},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,23]]}}}